Société de Therapeutique Marocaine S.A. Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 15 Fair Values set on narratives written by author
SOT Community Narratives
Sothema has demonstrated robust growth through strategic product innovation and international expansion.
Sothema has demonstrated robust growth through strategic product innovation and international expansion.
View narrativeTrending Discussion
No trending discussion available.
Recently Updated Narratives
Sothema has demonstrated robust growth through strategic product innovation and international expansion.
Snowflake Analysis
Société de Therapeutique Marocaine S.A. Key Details
- 10.06
- 48.03%
- 11.95%
- 36.9%
About SOT
- Founded
- 1976
- Employees
- 1271
- CEO
- Website
View website
Société de Therapeutique Marocaine S.A., a pharmaceutical company, engages in the manufacturing of licensed medicines in Morocco. It offers products in various therapeutic areas, such as allergology, antibiotic, oncology, cardiology, dental, dermatology, endocrinology, gastroenterology, gynecology, ophthalmology, ENT, pediatric, pulmonology, reanimation, rheumatology, central nervous system (CNS), and urology, as well as antibiotics and generics. The company also provides its products in various forms, including tablets, capsules, pouches, syrups, suspensions, powders, collyriums, flexible pouches, suppositories, creams and pomades, injectable solutions, and self-injectable syringes. In addition, it imports licensed medicines and dental products, as well as biotechnology products; and involved in subcontracted production. The company exports its products to Europe, Maghreb, Sub-Saharan Africa, and the Persian Gulf. Société de Therapeutique Marocaine S.A. was founded in 1976 and is based in Bouskoura, Morocco.